Dr Bunnapradist discusses his authorship in the ProActive Study and unmet need in seemingly stable populations / subclinical rejection

What is the difference between this test and our regular or routine labs

Why does monitoring matter

What is the process to use Natera's Prospera test

Two thresholds, one powerful solution: Combining the quantity and fraction of dd-cfDNA in a single blood test to improve the accuracy of non

Learn how the addition of DQS significantly reduces the rate of false positive results and improves the accuracy of detecting both acute cellular rejection (ACR) and antibody mediated rejection (AMR).

Dr. Rao DQS case studies

Dr. Lampert DQS case studies

Brian's Story: Surveilling with Prospera caught rejection early and saved his kidney

Video para Pacientes de Prospera

How to Engage Your Kidney Transplant Recipients

Being Proactive with Prospera on Their Transplant Care

How Dr. Hajjiri established Prospera™ monitoring protocols for low immunological risk, high immunological risk developing Acute kidney Injur